We are live on
!
Find out more
FP
Foundry Partners Portfolio holdings
AUM
$1.89B
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter
Est. Return
+9.32%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$2.82B
AUM Growth
+$36.8M
(+1.3%)
Cap. Flow
-$165M
Cap. Flow
% of AUM
-5.86%
Top 10 Holdings %
Top 10 Hldgs %
13.6%
Holding
389
New
26
Increased
102
Reduced
170
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$31.1M |
| 2 |
Pfizer
PFE
|
+$22.4M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$20.4M |
| 4 |
The Mosaic Company
MOS
|
+$18.2M |
| 5 |
Quest Diagnostics
DGX
|
+$17.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$34.7M |
| 2 |
3M
MMM
|
+$23.1M |
| 3 |
LyondellBasell Industries
LYB
|
+$16.9M |
| 4 |
Universal Health Services
UHS
|
+$14.6M |
| 5 |
Rithm Capital
RITM
|
+$13.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.04% |
| 2 | Industrials | 15.8% |
| 3 | Technology | 12.05% |
| 4 | Healthcare | 11.51% |
| 5 | Consumer Discretionary | 9% |
Similar funds
ST
UH
PAME
TW
AP
MBA
SSB
CC
Foundry Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Foundry Partners held 389 positions worth $2.82B, up 1.3% from $2.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Foundry Partners withdrew a net $165M in Q4 2021, closing 44 positions and reducing 170 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $34.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.
Against the trend, Foundry Partners opened a new position in Cisco worth $34.5M.
- Foundry Partners's largest Q4 2021 buy was Cisco: 544,210 shares worth $34.5M.
- Foundry Partners added most to C.H. Robinson in Q4 2021, an estimated $17.2M increase.
- Foundry Partners's biggest Q4 2021 reduction was Rithm Capital, cutting an estimated $13.8M.
- Foundry Partners fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $34.7M.
- Foundry Partners's ten largest holdings make up 14% of its $2.82B portfolio in Q4 2021.
- Foundry Partners opened 26 new positions and closed 44 in Q4 2021.
- Foundry Partners's portfolio value rose 1.3% quarter-over-quarter to $2.82B.
Based on Foundry Partners's 13F filing for Q4 2021, filed 26 Jan 2022.